Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Jason Cole. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Jason Cole har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:BLUE / bluebird bio, Inc. | Chief Strategy & Financial Off | 189 546 |
US:ZLCS / | EVP,Corp Dev & General Counsel | 280 000 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Jason Cole. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Jason Cole som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-08-23 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −14 194 | 189 546 | −6,97 | 5,53 | −78 473 | 1 047 924 | |
2022-08-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −7 448 | 203 740 | −3,53 | 4,39 | −32 707 | 894 704 | |
2022-02-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 50 000 | 50 000 | |||||
2022-02-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 25 000 | 211 188 | 13,43 | ||||
2022-01-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −3 387 | 186 188 | −1,79 | 9,64 | −32 659 | 1 795 336 | |
2022-01-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −1 584 | 189 575 | −0,83 | 9,40 | −14 893 | 1 782 422 | |
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −27 500 | 55 211 | −33,25 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −18 000 | 17 721 | −50,39 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −25 000 | 24 613 | −50,39 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −25 000 | 24 613 | −50,39 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −28 500 | 28 059 | −50,39 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −8 938 | 8 799 | −50,39 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
J - Other | −35 000 | 34 458 | −50,39 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
J - Other | 64 779 | 191 159 | 51,26 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
J - Other | 64 781 | 126 380 | 105,17 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
J - Other | 27 606 | 61 599 | 81,21 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
J - Other | 6 645 | 33 993 | 24,30 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
J - Other | 3 077 | 27 348 | 12,68 | ||||
2021-11-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
J - Other | 1 539 | 24 271 | 6,77 | ||||
2021-08-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 32 265 | 112 453 | 40,24 | ||||
2021-08-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 32 266 | 80 188 | 67,33 | ||||
2021-05-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −38 | 47 922 | −0,08 | 30,15 | −1 146 | 1 444 901 | |
2021-04-07 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −37 | 47 960 | −0,08 | 30,21 | −1 118 | 1 448 637 | |
2021-03-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −38 | 47 997 | −0,08 | 29,58 | −1 124 | 1 419 842 | |
2021-02-18 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −665 | 48 035 | −1,37 | 28,16 | −18 727 | 1 352 728 | |
2021-02-18 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 27 500 | 27 500 | |||||
2021-02-18 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 2 165 | 48 700 | 4,65 | ||||
2021-02-18 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 13 750 | 46 535 | 41,94 | ||||
2021-02-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −38 | 32 785 | −0,12 | 45,93 | −1 745 | 1 505 661 | |
2021-01-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −986 | 32 823 | −2,92 | 45,46 | −44 827 | 1 492 248 | |
2021-01-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −1 372 | 33 809 | −3,90 | 44,76 | −61 409 | 1 513 244 | |
2021-01-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −43 | 35 181 | −0,12 | 44,95 | −1 933 | 1 581 463 | |
2020-12-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −1 | 35 224 | 0,00 | 46,50 | −46 | 1 637 916 | |
2020-12-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −37 | 35 225 | −0,10 | 46,19 | −1 709 | 1 627 025 | |
2020-11-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −4 | 35 262 | −0,01 | 54,43 | −218 | 1 919 452 | |
2020-11-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −7 | 35 266 | −0,02 | 53,83 | −377 | 1 898 270 | |
2020-11-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −26 | 35 273 | −0,07 | 52,51 | −1 365 | 1 852 139 | |
2020-10-06 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −38 | 35 299 | −0,11 | 52,76 | −2 005 | 1 862 552 | |
2020-09-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −36 | 35 337 | −0,10 | 58,60 | −2 110 | 2 070 812 | |
2020-08-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −9 | 35 373 | −0,03 | 60,98 | −549 | 2 157 084 | |
2020-08-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −28 | 35 382 | −0,08 | 60,32 | −1 689 | 2 134 179 | |
2020-07-07 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −38 | 35 410 | −0,11 | 61,57 | −2 340 | 2 180 293 | |
2020-06-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −29 | 35 448 | −0,08 | 64,24 | −1 863 | 2 277 293 | |
2020-06-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −9 | 35 477 | −0,03 | 63,36 | −570 | 2 247 915 | |
2020-05-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 437 | 35 486 | 4,22 | ||||
2020-03-04 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 18 000 | 18 000 | |||||
2020-03-04 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 9 000 | 34 049 | 35,93 | ||||
2020-01-09 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −1 957 | 25 049 | −7,25 | 89,97 | −176 074 | 2 253 689 | |
2019-05-14 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −562 | 8 938 | −5,92 | ||||
2019-05-14 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 562 | 27 006 | 2,13 | 50,51 | 28 387 | 1 364 073 | |
2019-02-27 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −4 000 | 9 500 | −29,63 | ||||
2019-02-27 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −2 248 | 0 | −100,00 | ||||
2019-02-27 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −525 | 26 444 | −1,95 | 151,41 | −79 491 | 4 003 936 |
2019-02-27 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −5 723 | 26 969 | −17,51 | 150,13 | −859 207 | 4 048 918 |
2019-02-27 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 4 000 | 32 692 | 13,94 | 50,51 | 202 040 | 1 651 273 | |
2019-02-27 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 2 248 | 28 692 | 8,50 | 22,53 | 50 647 | 646 431 | |
2019-02-05 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 25 000 | 25 000 | |||||
2019-02-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 6 250 | 26 444 | 30,95 | ||||
2019-01-09 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −488 | 20 194 | −2,36 | 114,31 | −55 781 | 2 308 295 | |
2019-01-09 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −928 | 20 682 | −4,29 | 113,29 | −105 133 | 2 343 053 | |
2018-08-10 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −4 438 | 2 248 | −66,38 | ||||
2018-08-10 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 4 438 | 21 610 | 25,84 | 22,53 | 99 988 | 486 873 | |
2018-07-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −326 | 17 172 | −1,86 | 172,66 | −56 289 | 2 964 998 |
2018-07-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −940 | 17 498 | −5,10 | 171,60 | −161 306 | 3 002 695 |
2018-07-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −970 | 18 438 | −5,00 | 170,68 | −165 556 | 3 146 928 |
2018-07-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 290 | 19 408 | −10,55 | 169,64 | −388 484 | 3 292 447 |
2018-07-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −600 | 21 698 | −2,69 | 168,47 | −101 080 | 3 655 390 |
2018-05-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −460 | 22 298 | −2,02 | 172,39 | −79 301 | 3 844 030 |
2018-05-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 890 | 22 758 | −7,67 | 171,24 | −323 653 | 3 897 194 |
2018-05-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −900 | 24 648 | −3,52 | 170,48 | −153 435 | 4 202 072 |
2018-05-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −400 | 25 548 | −1,54 | 169,19 | −67 675 | 4 322 402 |
2018-05-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −100 | 25 948 | −0,38 | 167,85 | −16 785 | 4 355 320 |
2018-02-05 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 25 000 | 25 000 | |||||
2018-02-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 6 250 | 26 048 | 31,57 | ||||
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −25 000 | 6 686 | −78,90 | ||||
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −118 | 19 798 | −0,59 | 203,60 | −24 025 | 4 030 873 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −296 | 19 916 | −1,46 | 202,68 | −59 993 | 4 036 573 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 113 | 20 212 | −5,22 | 201,57 | −224 352 | 4 074 214 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 062 | 21 325 | −4,74 | 200,88 | −213 336 | 4 283 804 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 003 | 22 387 | −4,29 | 199,43 | −200 031 | 4 464 693 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −710 | 23 390 | −2,95 | 198,46 | −140 908 | 4 642 026 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 027 | 24 100 | −7,76 | 197,61 | −400 548 | 4 762 309 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 458 | 26 127 | −8,60 | 196,63 | −483 325 | 5 137 446 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 951 | 28 585 | −9,36 | 195,57 | −577 116 | 5 590 266 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −6 743 | 31 536 | −17,62 | 194,65 | −1 312 543 | 6 138 568 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −5 359 | 38 279 | −12,28 | 193,74 | −1 038 275 | 7 416 330 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 160 | 43 638 | −2,59 | 192,49 | −223 290 | 8 399 944 |
2018-02-01 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 25 000 | 44 798 | 126,28 | 22,53 | 563 250 | 1 009 299 | |
2018-01-09 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −147 | 19 798 | −0,74 | 174,17 | −25 603 | 3 448 273 | |
2018-01-09 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −982 | 19 945 | −4,69 | 173,26 | −170 138 | 3 455 603 | |
2017-07-07 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −5 126 | 31 686 | −13,92 | ||||
2017-07-07 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 5 126 | 20 927 | 32,44 | 22,53 | 115 489 | 471 485 | |
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −435 | 13 500 | −3,12 | ||||
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −435 | 15 801 | −2,68 | 100,05 | −43 522 | 1 580 890 |
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 435 | 16 236 | 2,75 | 50,51 | 21 972 | 820 080 | |
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −1 740 | 13 935 | −11,10 | ||||
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −15 070 | 36 812 | −29,05 | ||||
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Comon Stock |
S - Sale | X | −16 810 | 15 801 | −51,55 | 100,22 | −1 684 705 | 1 583 583 |
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 1 740 | 32 611 | 5,64 | 50,51 | 87 887 | 1 647 182 | |
2017-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 15 070 | 30 871 | 95,37 | 22,53 | 339 527 | 695 524 | |
2017-04-28 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −3 750 | 51 882 | −6,74 | ||||
2017-04-28 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 3 750 | 15 801 | 31,12 | 22,53 | 84 488 | 355 997 | |
2017-03-20 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −4 930 | 55 632 | −8,14 | ||||
2017-03-20 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −4 930 | 12 051 | −29,03 | 100,07 | −493 366 | 1 205 995 |
2017-03-20 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 4 930 | 16 981 | 40,91 | 22,53 | 111 073 | 382 582 | |
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −5 225 | 15 675 | −25,00 | ||||
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −5 225 | 12 051 | −30,24 | 90,32 | −471 911 | 1 088 421 |
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 5 225 | 17 276 | 43,36 | 50,51 | 263 915 | 872 611 | |
2017-02-17 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −666 | 12 051 | −5,24 | 80,22 | −53 429 | 966 775 |
2017-02-16 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −3 772 | 12 717 | −22,88 | 80,01 | −301 808 | 1 017 523 |
2017-02-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 28 500 | 28 500 | |||||
2017-02-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 7 100 | 16 489 | 75,62 | ||||
2017-01-09 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −549 | 9 389 | −5,52 | 67,10 | −36 838 | 630 002 | |
2016-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 20 900 | 20 900 | |||||
2016-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 5 500 | 9 938 | 123,93 | ||||
2015-12-22 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | 4 438 | 60 562 | 7,91 | ||||
2015-12-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 4 438 | 4 438 | 22,53 | 99 988 | 99 988 | ||
2015-10-13 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −5 000 | 65 000 | −7,14 | ||||
2015-10-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −500 | 0 | −100,00 | 88,30 | −44 152 | |
2015-10-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 500 | 500 | −83,33 | 87,54 | −218 856 | 43 771 |
2015-10-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 000 | 3 000 | −40,00 | 85,77 | −171 533 | 257 299 |
2015-10-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 5 000 | 5 000 | 22,53 | 112 650 | 112 650 | ||
2015-09-11 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −2 000 | 70 000 | −2,78 | ||||
2015-09-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −300 | 0 | −100,00 | 138,31 | −41 492 | |
2015-09-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 000 | 300 | −76,92 | 136,91 | −136 915 | 41 074 |
2015-09-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −700 | 1 300 | −35,00 | 135,30 | −94 713 | 175 895 |
2015-09-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 2 000 | 2 000 | 22,53 | 45 060 | 45 060 | ||
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −2 000 | 72 000 | −2,70 | ||||
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −119 | 0 | −100,00 | 152,86 | −18 191 | |
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −168 | 119 | −58,54 | 151,71 | −25 487 | 18 053 |
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −220 | 287 | −43,39 | 150,28 | −33 062 | 43 131 |
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −258 | 507 | −33,73 | 148,75 | −38 378 | 75 418 |
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −402 | 765 | −34,45 | 147,89 | −59 453 | 113 139 |
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −833 | 1 167 | −41,65 | 146,83 | −122 311 | 171 352 |
2015-08-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 2 000 | 2 000 | 22,53 | 45 060 | 45 060 | ||
2015-07-13 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −5 000 | 74 000 | −6,33 | ||||
2015-07-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −200 | 0 | −100,00 | 156,86 | −31 372 | |
2015-07-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 100 | 200 | −84,62 | 157,40 | −173 142 | 31 480 |
2015-07-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −3 300 | 1 300 | −71,74 | 158,37 | −522 623 | 205 882 |
2015-07-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −400 | 4 600 | −8,00 | 159,56 | −63 826 | 733 999 |
2015-07-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 5 000 | 5 000 | 22,53 | 112 650 | 112 650 | ||
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −2 000 | 79 000 | −2,47 | ||||
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −672 | 0 | −100,00 | 184,62 | −124 065 | |
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −381 | 672 | −36,18 | 185,53 | −70 686 | 124 674 |
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −368 | 1 053 | −25,90 | 186,60 | −68 667 | 196 485 |
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −447 | 1 421 | −23,93 | 187,72 | −83 911 | 266 751 |
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −132 | 1 868 | −6,60 | 188,24 | −24 847 | 351 626 |
2015-06-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 2 000 | 2 000 | 22,53 | 45 060 | 45 060 | ||
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −9 000 | 81 000 | −10,00 | ||||
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 003 | 0 | −100,00 | 167,26 | −167 760 | |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 560 | 1 003 | −60,87 | 166,41 | −259 594 | 166 906 |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −920 | 2 563 | −26,41 | 165,24 | −152 017 | 423 499 |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 066 | 3 483 | −23,43 | 164,06 | −174 886 | 571 416 |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 403 | 4 549 | −23,57 | 162,83 | −228 452 | 740 717 |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −2 128 | 5 952 | −26,34 | 161,96 | −344 645 | 963 969 |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −920 | 8 080 | −10,22 | 160,80 | −147 939 | 1 299 287 |
2015-05-13 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 9 000 | 9 000 | 22,53 | 202 770 | 202 770 | ||
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −10 000 | 90 000 | −10,00 | ||||
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 114,58 | −11 458 | |
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 617 | 100 | −94,18 | 113,42 | −183 395 | 11 342 |
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 809 | 1 717 | −51,30 | 112,41 | −203 357 | 193 015 |
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −1 994 | 3 526 | −36,12 | 111,47 | −222 263 | 393 028 |
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | X | −4 480 | 5 520 | −44,80 | 110,42 | −494 693 | 609 533 |
2015-03-11 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 10 000 | 10 000 | 22,53 | 225 300 | 225 300 | ||
2015-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 35 000 | 35 000 | |||||
2014-04-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 100 000 | 100 000 | |||||
2014-03-12 | 3 | BLUE |
bluebird bio, Inc.
No securities are beneficially owned |
0 | ||||||||
2013-01-07 |
|
4 | ZLCS |
Zalicus Inc.
Stock Option (Right to Buy) |
A - Award | 280 000 | 280 000 | |||||
2012-01-31 |
|
4 | ZLCS |
Zalicus Inc.
Common Stock |
S - Sale | X | −2 420 | 15 086 | −13,82 | 1,09 | −2 638 | 16 444 |
2012-01-27 |
|
4 | ZLCS |
Zalicus Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 242 809 | 242 809 | |||||
2012-01-27 |
|
4 | ZLCS |
Zalicus Inc.
Incentive Stock Option (right to buy) |
A - Award | 107 191 | 107 191 | |||||
2006-01-25 | 3 | CRXX |
COMBINATORX, INC
No Securities Beneficially Owned |
0 |